KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
About KESTRA MEDICAL TECHNOLOGIES, LTD.
Kestra Medical Technologies Ltd is a commercial-stage wearable medical device and digital healthcare company focused on connected monitoring, therapeutic intervention, and data-driven clinical insights for cardiovascular disease. It has developed and is commercializing the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. The platform is anchored by the ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also includes digital patient engagement and clinical workflow solutions.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $59.8M
- Net income
- -$113.8M
- Total assets
- $295.7M
- Market cap
- $1.2B
- Gross margin
- 40.5%
- Operating margin
- -177.8%
- Net margin
- -190.3%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $59.8M
- Cost of revenue
- $35.6M
- Gross profit
- $24.2M
- Operating expenses
- $130.6M
- Operating income
- -$106.4M
- Income tax
- $135.0K
- Net income
- -$113.8M
- EPS (basic)
- $-5.13
- EPS (diluted)
- $-5.13
Balance sheet
- Total assets
- $295.7M
- Current assets
- $255.3M
- Total liabilities
- $90.3M
- Current liabilities
- $38.0M
- Shareholders’ equity
- $205.4M
Cash flow
- Operating cash flow
- -$77.6M
- Investing cash flow
- -$23.3M
- Financing cash flow
- $330.3M
- Net cash flow
- $229.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.2B
- EPS (diluted)
- $-5.13
- Shares outstanding
- 47.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 6, 2025
Kestra Medical Technologies, Ltd. (KMTS) Stock Price
- Reported a net loss of $113.8M in FY2025.
- Gross margin of 40.5%, net margin -190.3%.
- Trading 9% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review KESTRA MEDICAL TECHNOLOGIES, LTD..
Write a review
News about KESTRA MEDICAL TECHNOLOGIES, LTD.
News & sentiment via Polygon.io
Kestra Medical Technologies, Ltd.: frequently asked questions
Is Kestra Medical Technologies, Ltd. an American company?
Kestra Medical Technologies, Ltd. is a US-based company headquartered in Kirkland, Washington, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Kestra Medical Technologies, Ltd. headquartered?
Kestra Medical Technologies, Ltd. is headquartered in Kirkland, Washington, United States.
Is Kestra Medical Technologies, Ltd. publicly traded?
Yes — Kestra Medical Technologies, Ltd. is a publicly traded company. Its stock trades under the ticker symbol KMTS on the NASDAQ.
What does Kestra Medical Technologies, Ltd. do?
Kestra Medical Technologies, Ltd. is an American Medical Devices company in the Health & Beauty sector.
